Prospective validation of the metastatic colorectal cancer score (mCCS) in patients with RAS wild-type metastatic colorectal cancer treated with first-line panitumumab plus FOLFIRI/FOLFOX: Final results of the non-interventional study VALIDATE

10. Oktober 2025

Potthoff K, Uhlig J, Jacobasch L, Müller L, Reiser M, Schuch A, Serrer L, de Buhr RK, Siebenbach HU, Göhler T, Schröder J, Semsek D, Köhler A, Stübs P, Marschner N.

Int J Cancer. 2025; 1-12. doi:10.1002/ijc.70139

Abstract